Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer.

J Cancer Res Clin Oncol · 2024 · PMC11291532 · PMID 39085623

Europe PMC DOI

hedged sentence

0.0013

closest p · 0.0× alpha

0.0013

boldest claim

The sentences

extraordinarily significantP = 0.0013actually significant

Remarkably, this surgery-induced survival difference was extraordinarily significant in the N1-PR cohort ( P = 0.0013, Fig. 6 C).

also in 43 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.